title: H-ferritin is the major source of iron for oligodendrocytes.
abstract: There is a critical relationship between oligodendrocyte development, myelin production, and iron bioavailability. Iron deficiency leads to hypomyelination both in humans and animal models, and the neurological sequelae of hypomyelination are significant. Therefore, understanding molecular mechanisms of iron import into oligodendrocytes is necessary for devising effective strategies for iron supplementation. Although transferrin has been considered as an essential component of oligodendrocyte media in culture, oligodendrocytes in vivo lack transferrin receptors. We have established that receptors for H-ferritin (HF) exist on cells of oligodendroglial lineage and that uptake of extracellular HF by oligodendrocyte progenitors is via receptor mediated endocytosis. These data strongly argue that ferritin is a major source of iron for oligodendrocytes. In this study, we demonstrate that media deficient in transferrin results in loss of viability of oligodendrocyte progenitors in culture. Cell loss could be prevented by supplementing the media with HF. Moreover, the addition of extracellular HF stimulates development of oligodendrocyte progenitor cells (OPCs) by increasing expression of myelin basic protein (MBP) and olig2 proteins without increasing their proliferation. The effect of HF on the OPCs could be mimicked by addition of membrane permeable 3,5,5-trimethylhexanoyl ferrocene (TMH-Fe) as an iron source to the media, but not membrane-impermeable ferric ammonium citrate. Overall, therefore, our results demonstrate the importance of iron for OPCs viability and differentiation and identify extracellular HF as a critical source of iron for oligodendrocytes. Given that ferritin receptors, but not transferrin receptors can be demonstrated on oligodendrocytes in vivo, the delivery of iron to oligodendrocytes via ferritin may be the more biological relevant delivery system.
authors: Department of Neurosurgery, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
authors: Bozho
authors: B
authors: Todorich
authors: Xuesheng
authors: X
authors: Zhang
authors: James R
authors: JR
authors: Connor
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001052:Apoferritins / Q000737:chemistry* / Q000502:physiology; D002454:Cell Differentiation / Q000187:drug effects / Q000235:genetics; D002478:Cells, Cultured; D003470:Culture Media / Q000494:pharmacology; D007501:Iron / Q000737:chemistry / Q000502:physiology*; D033862:Iron-Binding Proteins / Q000187:drug effects / Q000502:physiology; D009836:Oligodendroglia / Q000737:chemistry / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000502:physiology; D013234:Stem Cells / Q000737:chemistry / Q000166:cytology / Q000378:metabolism*; D014168:Transferrin / Q000172:deficiency / Q000235:genetics
chemical_list: D003470:Culture Media; D033862:Iron-Binding Proteins; D011956:Receptors, Cell Surface; D014168:Transferrin; C027293:ferritin receptor; D001052:Apoferritins; D007501:Iron